Comparison between Arrowhead Seperation Engineering IPO and Sunrest Lifescience IPO.
Arrowhead Seperation Engineering IPO is a SME Fixed Price IPO proposed to list at BSE SME while Sunrest Lifescience IPO is a SME Fixed Price proposed to list at NSE SME.
| Arrowhead Seperation Engineering IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | Mark Corporate Advisors Pvt.Ltd. |
| Registrar | Cameo Corporate Services Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Svcm Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Arrowhead Seperation Engineering IPO is up to ₹12.30 Cr whereas the issue size of the Sunrest Lifescience IPO is up to ₹10.30 Cr. The final issue price of Arrowhead Seperation Engineering IPO is ₹233.00 per share and of Sunrest Lifescience IPO is ₹84.00 per share.
| Arrowhead Seperation Engineering IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹233.00 per share | ₹84.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 1600 shares |
| Fresh Issue Size | 5,28,000 shares | 12,25,600 shares |
| Fresh Issue Size (Amount) | up to ₹12.30 Cr | up to ₹10.30 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,28,000 shares | 12,25,600 shares |
| Issue Size Total (Amount) | up to ₹12.30 Cr | up to ₹10.30 Cr |
Arrowhead Seperation Engineering IPO opens on Nov 16, 2023, while Sunrest Lifescience IPO opens on Nov 07, 2023. The closing date of Arrowhead Seperation Engineering IPO and Sunrest Lifescience IPO is Nov 20, 2023, and Nov 09, 2023, respectively.
| Arrowhead Seperation Engineering IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Nov 16, 2023 | Nov 07, 2023 |
| Issue Close | Nov 20, 2023 | Nov 09, 2023 |
| Basis Of Allotment (Tentative) | Nov 23, 2023 | Nov 15, 2023 |
| Initiation of Refunds (Tentative) | Nov 24, 2023 | Nov 16, 2023 |
| Credit of Share (Tentative) | Nov 28, 2023 | Nov 17, 2023 |
| Listing date (Tentative) | Nov 28, 2023 | Nov 20, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Arrowhead Seperation Engineering IPO P/E ratio is 18.09, as compared to Sunrest Lifescience IPO P/E ratio of 12.33.
| Arrowhead Seperation Engineering IPO | Sunrest Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Arrowhead Seperation Engineering Limited Financial Information (Restated)Arrowhead Seperation Engineering Limited's revenue increased by 98.91% and profit after tax (PAT) rose by 1744.93% between the financial year ending with March 31, 2023 and March 31, 2022.
| Sunrest Lifescience Limited Financial Information (Restated)Sunrest Lifescience Limited's revenue decreased by -8.32% and profit after tax (PAT) rose by 162.91% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 50 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 35.09 | 69.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 18.09 | 12.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹43.60 Cr. | ₹36.05 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 105% | 53% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 30.94% | 98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 3.30 | 0.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.88 | ₹6.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 68.75% | 65.59% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Arrowhead Seperation Engineering IPO Retail Individual Investors (RII) are offered 2,64,000 shares while in Sunrest Lifescience IPO retail investors are offered 2,64,000 shares. Qualified Institutional Buyers (QIB) are offered in Arrowhead Seperation Engineering IPO and in Sunrest Lifescience IPO.
| Arrowhead Seperation Engineering IPO | Sunrest Lifescience IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 30,000 shares | 65,600 shares |
| QIB | ||
| NII | 2,64,000 shares | 6,12,800 shares |
| RII | 2,64,000 shares | 6,12,800 shares |
| Employee | ||
| Others | ||
| Total | 5,28,000 shares | 12,25,600 shares |
Arrowhead Seperation Engineering IPO subscribed 94.79x in total, whereas Sunrest Lifescience IPO subscribed 48.54x.
| Arrowhead Seperation Engineering IPO | Sunrest Lifescience IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 46.02x | 29.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 142.30x | 65.74x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 94.79x | 48.54x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
